Thomas Faitg
- Co-authors
- Jean‐Yves LallemandLouis RicardFrançois MatheyFrançois MercierMalini IyengarJean‐François BetzerJean‐Marc NavenotGwendolyn K. Binder
- Topics
- CAR-T cell therapy research (8 papers)Immunotherapy and Immune Responses (7 papers)Multiple Myeloma Research and Treatments (3 papers)
- Cited by
- OncologyOrganic ChemistryImmunology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Thomas Faitg
13 papers receiving 197 citations
Peers
Comparison fields: 5 of 35
- Oncology 98
- Organic Chemistry 80
- Molecular Biology 62
- Immunology 47
- Inorganic Chemistry 22
Countries citing papers authored by Thomas Faitg
This map shows the geographic impact of Thomas Faitg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Faitg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Faitg more than expected).
Fields of papers citing papers by Thomas Faitg
This network shows the impact of papers produced by Thomas Faitg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Faitg. The network helps show where Thomas Faitg may publish in the future.
Co-authorship network of co-authors of Thomas Faitg
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Faitg. A scholar is included among the top collaborators of Thomas Faitg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Faitg. Thomas Faitg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 69 | |
| 9 | 2 | |
| 10 | 17 | |
| 11 | 8 | |
| 12 | 29 | |
| 13 | 30 | |
| 14 | 18 |
About Thomas Faitg
Thomas Faitg is a scholar working on Immunology, Oncology and Hematology, having authored 14 papers that have together received 199 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (7 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Oncology (98 citations), Organic Chemistry (80 citations) and Immunology (47 citations). Thomas Faitg has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Jean‐Yves Lallemand, Louis Ricard, François Mathey, François Mercier, Malini Iyengar, Jean‐François Betzer, Jean‐Marc Navenot, Gwendolyn K. Binder, Trupti Trivedi and Edward A. Stadtmauer. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.